Turmeric in dal. Ginger in chai.Black pepper in soups. These all spices are part of indian household. People have believed that they carry healing properties. Grandmothers often spoke about turmeric for inflammation or ginger for digestion. Scientists are looking at these same spices from a different angle now. Not in the kitchen. Inside research laboratories. And the reason is quite interesting.
A new direction in cancer research
Scientists have been aware that some spices possess potent natural compounds. Curcumin is found in turmeric, gingerol in ginger, and piperine in black pepper. The compounds affect inflammation and other biological activities within the body. In laboratory experiments, researchers observed that some of these substances are able to react with cancer cells. Nonetheless, there has been one big challenge. The majority of these compounds are not readily absorbed by the body. They decompose fast, or they do not reach those tissues where they could be of use.
What nanomedicine means
Nanomedicine uses extremely tiny particles to deliver medicines inside the body. These particles are a thousand times smaller than a human hair and are capable of transporting drug molecules in the blood. Think of them as protective barriers. Instead of breaking down too early, the nanoparticle helps carry the compound to specific tissues and release it gradually. This methodology has the potential to enhance the efficacy of some drugs in the body.
What research says
In 2024, researchers at the Indian Institute of Technology Madras developed and patented a nanomedicine created from oils extracted from Indian spices. Early studies showed promising results. In laboratory experiments, these spice-derived nanoformulations showed activity against several types of cancer cells, including breast, lung, colon, cervical, oral, and thyroid cancers.
Researchers reported that in some early tests, the formulations showed around 70–80% effectiveness against certain cancer cells, while appearing less harmful to normal healthy cells. Animal studies have already been completed, and the research team is preparing to begin human clinical trials.
What Happens Next
Although the results are promising, the study is in its initial stages. Clinical trials will be required to learn how these nanomedicines will behave in the human body and whether they are safe and effective in patients.
If future studies go well, researchers believe these treatments could become available around 2027 or 2028. For now, the work is going on in research laboratories. However, the concept itself is intriguing that the same ingredients that are lying in Indian kitchens may one day be used to develop advanced cancer treatments using modern nanotechnology. It. Sometimes science doesn’t always search for answers in distant places. Sometimes, it simply looks again at what has been in front of us all along.